Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 2
2009 2
2010 2
2012 1
2013 2
2015 1
2016 3
2017 3
2018 5
2019 6
2020 10
2021 7
2022 7
2023 8
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Results by year

Filters applied: . Clear all
Page 1
Outcomes of polatuzumab vedotin-containing regimens in real-world setting of relapsed and or refractory diffuse large B-cell lymphoma patients: a matched-control analysis from the Thai Lymphoma Study Group (TLSG).
Rattanathammethee T, Norasetthada L, Bunworasate U, Wudhikarn K, Julamanee J, Noiperm P, Lanamtieng T, Phiphitaporn P, Navinpipat M, Kanya P, Jit-Ueakul D, Wongkhantee S, Suwannathen T, Chaloemwong J, Wong P, Makruasi N, Khuhapinant A, Prayongratana K, Niparuck P, Kanitsap N, Suwanban T, Intragumtornchai T. Rattanathammethee T, et al. Among authors: niparuck p. Ann Hematol. 2023 Jul;102(7):1887-1895. doi: 10.1007/s00277-023-05273-8. Epub 2023 May 18. Ann Hematol. 2023. PMID: 37202499
Cytotoxicity and exhaustion markers of chimeric antigen receptor T cells targeting BCMA in multiple myeloma cell lines between patients and healthy donors.
Prasongtanakij S, Preedagasamzin S, Jittorntrum B, Anurathapan U, Puavilai T, Niparuck P, Chantrathammachart P, Piyajaroenkij T, Uaesoontrachoon K, Uchibori R, Ozawa K, Ohmine K, Hongeng S. Prasongtanakij S, et al. Among authors: niparuck p. Eur J Haematol. 2024 Feb;112(2):248-256. doi: 10.1111/ejh.14007. Epub 2023 May 24. Eur J Haematol. 2024. PMID: 37222081
Treatment outcome and prognostic factors in PCNSL.
Niparuck P, Boonsakan P, Sutthippingkiat T, Pukiat S, Chantrathammachart P, Phusanti S, Boonyawat K, Puavilai T, Angchaisuksiri P, Ungkanont A, Chuncharunee S, Atichartakarn V. Niparuck P, et al. Diagn Pathol. 2019 Jun 13;14(1):56. doi: 10.1186/s13000-019-0833-1. Diagn Pathol. 2019. PMID: 31189479 Free PMC article.
Does leukocytosis remain a predictive factor for survival outcomes in patients with acute promyelocytic leukemia receiving ATRA plus a chemotherapy-based regimen? A prospective multicenter analysis from TALWG.
Kungwankiattichai S, Owattanapanich W, Rattanathammethee T, Rattarittamrong E, Chanswangphuwana C, Polprasert C, Limvorapitak W, Saengboon S, Niparuck P, Puavilai T, Julamanee J, Saelue P, Wanitpongpun C, Prayongratana K, Sriswasdi C, Nakhakes C. Kungwankiattichai S, et al. Among authors: niparuck p. Hematology. 2023 Dec;28(1):2191462. doi: 10.1080/16078454.2023.2191462. Hematology. 2023. PMID: 36951362
Novel DDX41 variants in Thai patients with myeloid neoplasms.
Polprasert C, Takeda J, Niparuck P, Rattanathammethee T, Pirunsarn A, Suksusut A, Kobbuaklee S, Wudhikarn K, Lawasut P, Kongkiatkamon S, Chuncharunee S, Songserm K, Phowthongkum P, Bunworasate U, Nannya Y, Yoshida K, Makishima H, Ogawa S, Rojnuckarin P. Polprasert C, et al. Among authors: niparuck p. Int J Hematol. 2020 Feb;111(2):241-246. doi: 10.1007/s12185-019-02770-3. Epub 2019 Nov 11. Int J Hematol. 2020. PMID: 31713024
Genetic mutations associated with blood count abnormalities in myeloid neoplasms.
Polprasert C, Kongkiatkamon S, Niparuck P, Rattanathammethee T, Wudhikarn K, Chuncharunee S, Kobbuaklee S, Suksusut A, Lanamtieng T, Lawasut P, Asawapanumas T, Bunworasate U, Rojnuckarin P. Polprasert C, et al. Among authors: niparuck p. Hematology. 2022 Dec;27(1):765-771. doi: 10.1080/16078454.2022.2094134. Hematology. 2022. PMID: 35766510
Excellent Prognosis of Low-Risk Myelodysplastic Syndromes (MDS) Without Detectable Myeloid-Related Mutations.
Polprasert C, Niparuck P, Rattanathammethee T, Chuncharunee S, Kobbuaklee S, Songserm K, Suksusut A, Trithiphen S, Lanamtieng T, Kongkiatkamon S, Chanswangphuwana C, Lawasut P, Bunworasate U, Rojnuckarin P. Polprasert C, et al. Among authors: niparuck p. Clin Lymphoma Myeloma Leuk. 2022 May;22(5):e293-e299. doi: 10.1016/j.clml.2021.10.015. Epub 2021 Nov 2. Clin Lymphoma Myeloma Leuk. 2022. PMID: 34840089
Treatment Outcomes and Clinical Relevance in Patients with Double Expressor DLBCL.
Rungwittayatiwat S, Boonsakan P, Chantrathammachart P, Puavilai T, Pukiat S, Phusanti S, Boonyawat K, Wacharapornin P, Angchaisuksiri P, Ungkanont A, Chuncharunee S, Niparuck P. Rungwittayatiwat S, et al. Among authors: niparuck p. Mediterr J Hematol Infect Dis. 2021 Nov 1;13(1):e2021063. doi: 10.4084/MJHID.2021.063. eCollection 2021. Mediterr J Hematol Infect Dis. 2021. PMID: 34804437 Free PMC article.
MYH9 disorder: Identification and a novel mutation in patients with macrothrombocytopenia.
Natesirinilkul R, Sosothikul D, Komwilaisak P, Pongtanakul B, Narkbunnum N, Yudhasompop N, Mekjarusgool P, Niparuck P, Boonyawat K, Kunishima S, Sirachainan N; Thai Macrothrombocytopenia Study Group. Natesirinilkul R, et al. Among authors: niparuck p. Pediatr Blood Cancer. 2021 Jul;68(7):e29055. doi: 10.1002/pbc.29055. Epub 2021 Apr 15. Pediatr Blood Cancer. 2021. PMID: 33855781
51 results